0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Anti-Thrombotic Coating Market Research Report 2026
Published Date: 2026-03-24
|
Report Code: QYRE-Auto-36R17519
Home | Market Reports | Health| Nursing
Global Medical Anti Thrombotic Coating Market Research Report 2024
BUY CHAPTERS

Global Medical Anti-Thrombotic Coating Market Research Report 2026

Code: QYRE-Auto-36R17519
Report
2026-03-24
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Anti-Thrombotic Coating Market

The global Medical Anti-Thrombotic Coating market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Anti-Thrombotic Coating competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Medical Anti-Thrombotic Coating is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Medical Anti-Thrombotic Coating is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Medical Anti-Thrombotic Coating include DSM Biomedical, Surmodics, Specialty Coating Systems (SCS), Biocoat, Coatings2Go, Thermal Spray Technologies, Hydromer, Harland Medical Systems, AST Products, Precision Coating, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Medical Anti-Thrombotic Coating market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Anti-Thrombotic Coating. The Medical Anti-Thrombotic Coating market size, estimates, and forecasts are provided in terms of sales volume (Kilotons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Anti-Thrombotic Coating market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Anti-Thrombotic Coating manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Medical Anti-Thrombotic Coating Market Report

Report Metric Details
Report Name Medical Anti-Thrombotic Coating Market
Segment by Type
  • Thin Coating
  • Thick Coating
by Application
  • Catheter
  • Stent Delivery System
  • Guide Wire
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company DSM Biomedical, Surmodics, Specialty Coating Systems (SCS), Biocoat, Coatings2Go, Thermal Spray Technologies, Hydromer, Harland Medical Systems, AST Products, Precision Coating, Surface Solutions Group, ISurTec, Whitford, AdvanSource Biomaterials, Jiangsu Biosurf Biotech, jMedtech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Anti-Thrombotic Coating manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Medical Anti-Thrombotic Coating sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Medical Anti-Thrombotic Coating Market report?

Ans: The main players in the Medical Anti-Thrombotic Coating Market are DSM Biomedical, Surmodics, Specialty Coating Systems (SCS), Biocoat, Coatings2Go, Thermal Spray Technologies, Hydromer, Harland Medical Systems, AST Products, Precision Coating, Surface Solutions Group, ISurTec, Whitford, AdvanSource Biomaterials, Jiangsu Biosurf Biotech, jMedtech

What are the Application segmentation covered in the Medical Anti-Thrombotic Coating Market report?

Ans: The Applications covered in the Medical Anti-Thrombotic Coating Market report are Catheter, Stent Delivery System, Guide Wire, Others

What are the Type segmentation covered in the Medical Anti-Thrombotic Coating Market report?

Ans: The Types covered in the Medical Anti-Thrombotic Coating Market report are Thin Coating, Thick Coating

1 Medical Anti-Thrombotic Coating Market Overview
1.1 Product Definition
1.2 Medical Anti-Thrombotic Coating by Type
1.2.1 Global Medical Anti-Thrombotic Coating Market Value by Type: 2025 vs 2032
1.2.2 Thin Coating
1.2.3 Thick Coating
1.3 Medical Anti-Thrombotic Coating by Application
1.3.1 Global Medical Anti-Thrombotic Coating Market Value by Application: 2025 vs 2032
1.3.2 Catheter
1.3.3 Stent Delivery System
1.3.4 Guide Wire
1.3.5 Others
1.4 Global Medical Anti-Thrombotic Coating Market Size Estimates and Forecasts
1.4.1 Global Medical Anti-Thrombotic Coating Revenue 2021–2032
1.4.2 Global Medical Anti-Thrombotic Coating Sales 2021–2032
1.4.3 Global Medical Anti-Thrombotic Coating Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Medical Anti-Thrombotic Coating Market Competition by Manufacturers
2.1 Global Medical Anti-Thrombotic Coating Sales Market Share by Manufacturers (2021–2026)
2.2 Global Medical Anti-Thrombotic Coating Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Medical Anti-Thrombotic Coating Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Medical Anti-Thrombotic Coating, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Medical Anti-Thrombotic Coating, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Medical Anti-Thrombotic Coating, Product Types and Applications
2.7 Global Key Manufacturers of Medical Anti-Thrombotic Coating, Date of Entry into the Industry
2.8 Global Medical Anti-Thrombotic Coating Market Competitive Situation and Trends
2.8.1 Global Medical Anti-Thrombotic Coating Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Medical Anti-Thrombotic Coating Players Market Share by Revenue
2.8.3 Global Medical Anti-Thrombotic Coating Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Anti-Thrombotic Coating Market Scenario by Region
3.1 Global Medical Anti-Thrombotic Coating Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Anti-Thrombotic Coating Sales by Region: 2021–2032
3.2.1 Global Medical Anti-Thrombotic Coating Sales by Region: 2021–2026
3.2.2 Global Medical Anti-Thrombotic Coating Sales by Region: 2027–2032
3.3 Global Medical Anti-Thrombotic Coating Revenue by Region: 2021–2032
3.3.1 Global Medical Anti-Thrombotic Coating Revenue by Region: 2021–2026
3.3.2 Global Medical Anti-Thrombotic Coating Revenue by Region: 2027–2032
3.4 North America Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.4.1 North America Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.4.3 North America Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.5.1 Europe Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.5.3 Europe Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Anti-Thrombotic Coating Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Anti-Thrombotic Coating Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Medical Anti-Thrombotic Coating Sales by Region (2021–2032)
3.6.3 Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.7.1 Latin America Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.7.3 Latin America Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Anti-Thrombotic Coating Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Anti-Thrombotic Coating Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Medical Anti-Thrombotic Coating Sales by Country (2021–2032)
3.8.3 Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Anti-Thrombotic Coating Sales by Type (2021–2032)
4.1.1 Global Medical Anti-Thrombotic Coating Sales by Type (2021–2026)
4.1.2 Global Medical Anti-Thrombotic Coating Sales by Type (2027–2032)
4.1.3 Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021–2032)
4.2 Global Medical Anti-Thrombotic Coating Revenue by Type (2021–2032)
4.2.1 Global Medical Anti-Thrombotic Coating Revenue by Type (2021–2026)
4.2.2 Global Medical Anti-Thrombotic Coating Revenue by Type (2027–2032)
4.2.3 Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021–2032)
4.3 Global Medical Anti-Thrombotic Coating Price by Type (2021–2032)
5 Segment by Application
5.1 Global Medical Anti-Thrombotic Coating Sales by Application (2021–2032)
5.1.1 Global Medical Anti-Thrombotic Coating Sales by Application (2021–2026)
5.1.2 Global Medical Anti-Thrombotic Coating Sales by Application (2027–2032)
5.1.3 Global Medical Anti-Thrombotic Coating Sales Market Share by Application (2021–2032)
5.2 Global Medical Anti-Thrombotic Coating Revenue by Application (2021–2032)
5.2.1 Global Medical Anti-Thrombotic Coating Revenue by Application (2021–2026)
5.2.2 Global Medical Anti-Thrombotic Coating Revenue by Application (2027–2032)
5.2.3 Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2021–2032)
5.3 Global Medical Anti-Thrombotic Coating Price by Application (2021–2032)
6 Key Companies Profiled
6.1 DSM Biomedical
6.1.1 DSM Biomedical Company Information
6.1.2 DSM Biomedical Description and Business Overview
6.1.3 DSM Biomedical Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 DSM Biomedical Medical Anti-Thrombotic Coating Product Portfolio
6.1.5 DSM Biomedical Recent Developments/Updates
6.2 Surmodics
6.2.1 Surmodics Company Information
6.2.2 Surmodics Description and Business Overview
6.2.3 Surmodics Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Surmodics Medical Anti-Thrombotic Coating Product Portfolio
6.2.5 Surmodics Recent Developments/Updates
6.3 Specialty Coating Systems (SCS)
6.3.1 Specialty Coating Systems (SCS) Company Information
6.3.2 Specialty Coating Systems (SCS) Description and Business Overview
6.3.3 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product Portfolio
6.3.5 Specialty Coating Systems (SCS) Recent Developments/Updates
6.4 Biocoat
6.4.1 Biocoat Company Information
6.4.2 Biocoat Description and Business Overview
6.4.3 Biocoat Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Biocoat Medical Anti-Thrombotic Coating Product Portfolio
6.4.5 Biocoat Recent Developments/Updates
6.5 Coatings2Go
6.5.1 Coatings2Go Company Information
6.5.2 Coatings2Go Description and Business Overview
6.5.3 Coatings2Go Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Coatings2Go Medical Anti-Thrombotic Coating Product Portfolio
6.5.5 Coatings2Go Recent Developments/Updates
6.6 Thermal Spray Technologies
6.6.1 Thermal Spray Technologies Company Information
6.6.2 Thermal Spray Technologies Description and Business Overview
6.6.3 Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Thermal Spray Technologies Medical Anti-Thrombotic Coating Product Portfolio
6.6.5 Thermal Spray Technologies Recent Developments/Updates
6.7 Hydromer
6.7.1 Hydromer Company Information
6.7.2 Hydromer Description and Business Overview
6.7.3 Hydromer Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hydromer Medical Anti-Thrombotic Coating Product Portfolio
6.7.5 Hydromer Recent Developments/Updates
6.8 Harland Medical Systems
6.8.1 Harland Medical Systems Company Information
6.8.2 Harland Medical Systems Description and Business Overview
6.8.3 Harland Medical Systems Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Harland Medical Systems Medical Anti-Thrombotic Coating Product Portfolio
6.8.5 Harland Medical Systems Recent Developments/Updates
6.9 AST Products
6.9.1 AST Products Company Information
6.9.2 AST Products Description and Business Overview
6.9.3 AST Products Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AST Products Medical Anti-Thrombotic Coating Product Portfolio
6.9.5 AST Products Recent Developments/Updates
6.10 Precision Coating
6.10.1 Precision Coating Company Information
6.10.2 Precision Coating Description and Business Overview
6.10.3 Precision Coating Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Precision Coating Medical Anti-Thrombotic Coating Product Portfolio
6.10.5 Precision Coating Recent Developments/Updates
6.11 Surface Solutions Group
6.11.1 Surface Solutions Group Company Information
6.11.2 Surface Solutions Group Description and Business Overview
6.11.3 Surface Solutions Group Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Surface Solutions Group Medical Anti-Thrombotic Coating Product Portfolio
6.11.5 Surface Solutions Group Recent Developments/Updates
6.12 ISurTec
6.12.1 ISurTec Company Information
6.12.2 ISurTec Description and Business Overview
6.12.3 ISurTec Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ISurTec Medical Anti-Thrombotic Coating Product Portfolio
6.12.5 ISurTec Recent Developments/Updates
6.13 Whitford
6.13.1 Whitford Company Information
6.13.2 Whitford Description and Business Overview
6.13.3 Whitford Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Whitford Medical Anti-Thrombotic Coating Product Portfolio
6.13.5 Whitford Recent Developments/Updates
6.14 AdvanSource Biomaterials
6.14.1 AdvanSource Biomaterials Company Information
6.14.2 AdvanSource Biomaterials Description and Business Overview
6.14.3 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product Portfolio
6.14.5 AdvanSource Biomaterials Recent Developments/Updates
6.15 Jiangsu Biosurf Biotech
6.15.1 Jiangsu Biosurf Biotech Company Information
6.15.2 Jiangsu Biosurf Biotech Description and Business Overview
6.15.3 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product Portfolio
6.15.5 Jiangsu Biosurf Biotech Recent Developments/Updates
6.16 jMedtech
6.16.1 jMedtech Company Information
6.16.2 jMedtech Description and Business Overview
6.16.3 jMedtech Medical Anti-Thrombotic Coating Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 jMedtech Medical Anti-Thrombotic Coating Product Portfolio
6.16.5 jMedtech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Anti-Thrombotic Coating Industry Chain Analysis
7.2 Medical Anti-Thrombotic Coating Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Anti-Thrombotic Coating Production Mode & Process Analysis
7.4 Medical Anti-Thrombotic Coating Sales and Marketing
7.4.1 Medical Anti-Thrombotic Coating Sales Channels
7.4.2 Medical Anti-Thrombotic Coating Distributors
7.5 Medical Anti-Thrombotic Coating Customer Analysis
8 Medical Anti-Thrombotic Coating Market Dynamics
8.1 Medical Anti-Thrombotic Coating Industry Trends
8.2 Medical Anti-Thrombotic Coating Market Drivers
8.3 Medical Anti-Thrombotic Coating Market Challenges
8.4 Medical Anti-Thrombotic Coating Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Medical Anti-Thrombotic Coating Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Medical Anti-Thrombotic Coating Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Medical Anti-Thrombotic Coating Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Medical Anti-Thrombotic Coating Sales (Kilotons) of Key Manufacturers (2021–2026)
 Table 5. Global Medical Anti-Thrombotic Coating Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Medical Anti-Thrombotic Coating Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Medical Anti-Thrombotic Coating Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Medical Anti-Thrombotic Coating, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Medical Anti-Thrombotic Coating, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Medical Anti-Thrombotic Coating, Product Types and Applications
 Table 12. Global Key Manufacturers of Medical Anti-Thrombotic Coating, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medical Anti-Thrombotic Coating Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Anti-Thrombotic Coating Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Anti-Thrombotic Coating Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2021–2026
 Table 18. Global Medical Anti-Thrombotic Coating Sales Market Share by Region (2021–2026)
 Table 19. Global Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2027–2032
 Table 20. Global Medical Anti-Thrombotic Coating Sales Market Share by Region (2027–2032)
 Table 21. Global Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Medical Anti-Thrombotic Coating Revenue Market Share by Region (2021–2026)
 Table 23. Global Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Medical Anti-Thrombotic Coating Revenue Market Share by Region (2027–2032)
 Table 25. North America Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
 Table 27. North America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
 Table 28. North America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
 Table 32. Europe Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
 Table 33. Europe Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2021–2026
 Table 37. Asia Pacific Medical Anti-Thrombotic Coating Sales by Region (Kilotons), 2027–2032
 Table 38. Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Medical Anti-Thrombotic Coating Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
 Table 42. Latin America Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
 Table 43. Latin America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2021–2026
 Table 47. Middle East and Africa Medical Anti-Thrombotic Coating Sales by Country (Kilotons), 2027–2032
 Table 48. Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Medical Anti-Thrombotic Coating Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Type (2021–2026)
 Table 51. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Type (2027–2032)
 Table 52. Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2021–2026)
 Table 53. Global Medical Anti-Thrombotic Coating Sales Market Share by Type (2027–2032)
 Table 54. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2021–2026)
 Table 57. Global Medical Anti-Thrombotic Coating Revenue Market Share by Type (2027–2032)
 Table 58. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Type (2021–2026)
 Table 59. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Type (2027–2032)
 Table 60. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Application (2021–2026)
 Table 61. Global Medical Anti-Thrombotic Coating Sales (Kilotons) by Application (2027–2032)
 Table 62. Global Medical Anti-Thrombotic Coating Sales Market Share by Application (2021–2026)
 Table 63. Global Medical Anti-Thrombotic Coating Sales Market Share by Application (2027–2032)
 Table 64. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Medical Anti-Thrombotic Coating Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2021–2026)
 Table 67. Global Medical Anti-Thrombotic Coating Revenue Market Share by Application (2027–2032)
 Table 68. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Application (2021–2026)
 Table 69. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Application (2027–2032)
 Table 70. DSM Biomedical Company Information
 Table 71. DSM Biomedical Description and Business Overview
 Table 72. DSM Biomedical Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 73. DSM Biomedical Medical Anti-Thrombotic Coating Product
 Table 74. DSM Biomedical Recent Developments/Updates
 Table 75. Surmodics Company Information
 Table 76. Surmodics Description and Business Overview
 Table 77. Surmodics Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 78. Surmodics Medical Anti-Thrombotic Coating Product
 Table 79. Surmodics Recent Developments/Updates
 Table 80. Specialty Coating Systems (SCS) Company Information
 Table 81. Specialty Coating Systems (SCS) Description and Business Overview
 Table 82. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 83. Specialty Coating Systems (SCS) Medical Anti-Thrombotic Coating Product
 Table 84. Specialty Coating Systems (SCS) Recent Developments/Updates
 Table 85. Biocoat Company Information
 Table 86. Biocoat Description and Business Overview
 Table 87. Biocoat Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 88. Biocoat Medical Anti-Thrombotic Coating Product
 Table 89. Biocoat Recent Developments/Updates
 Table 90. Coatings2Go Company Information
 Table 91. Coatings2Go Description and Business Overview
 Table 92. Coatings2Go Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 93. Coatings2Go Medical Anti-Thrombotic Coating Product
 Table 94. Coatings2Go Recent Developments/Updates
 Table 95. Thermal Spray Technologies Company Information
 Table 96. Thermal Spray Technologies Description and Business Overview
 Table 97. Thermal Spray Technologies Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 98. Thermal Spray Technologies Medical Anti-Thrombotic Coating Product
 Table 99. Thermal Spray Technologies Recent Developments/Updates
 Table 100. Hydromer Company Information
 Table 101. Hydromer Description and Business Overview
 Table 102. Hydromer Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 103. Hydromer Medical Anti-Thrombotic Coating Product
 Table 104. Hydromer Recent Developments/Updates
 Table 105. Harland Medical Systems Company Information
 Table 106. Harland Medical Systems Description and Business Overview
 Table 107. Harland Medical Systems Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 108. Harland Medical Systems Medical Anti-Thrombotic Coating Product
 Table 109. Harland Medical Systems Recent Developments/Updates
 Table 110. AST Products Company Information
 Table 111. AST Products Description and Business Overview
 Table 112. AST Products Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 113. AST Products Medical Anti-Thrombotic Coating Product
 Table 114. AST Products Recent Developments/Updates
 Table 115. Precision Coating Company Information
 Table 116. Precision Coating Description and Business Overview
 Table 117. Precision Coating Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 118. Precision Coating Medical Anti-Thrombotic Coating Product
 Table 119. Precision Coating Recent Developments/Updates
 Table 120. Surface Solutions Group Company Information
 Table 121. Surface Solutions Group Description and Business Overview
 Table 122. Surface Solutions Group Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 123. Surface Solutions Group Medical Anti-Thrombotic Coating Product
 Table 124. Surface Solutions Group Recent Developments/Updates
 Table 125. ISurTec Company Information
 Table 126. ISurTec Description and Business Overview
 Table 127. ISurTec Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 128. ISurTec Medical Anti-Thrombotic Coating Product
 Table 129. ISurTec Recent Developments/Updates
 Table 130. Whitford Company Information
 Table 131. Whitford Description and Business Overview
 Table 132. Whitford Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 133. Whitford Medical Anti-Thrombotic Coating Product
 Table 134. Whitford Recent Developments/Updates
 Table 135. AdvanSource Biomaterials Company Information
 Table 136. AdvanSource Biomaterials Description and Business Overview
 Table 137. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 138. AdvanSource Biomaterials Medical Anti-Thrombotic Coating Product
 Table 139. AdvanSource Biomaterials Recent Developments/Updates
 Table 140. Jiangsu Biosurf Biotech Company Information
 Table 141. Jiangsu Biosurf Biotech Description and Business Overview
 Table 142. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 143. Jiangsu Biosurf Biotech Medical Anti-Thrombotic Coating Product
 Table 144. Jiangsu Biosurf Biotech Recent Developments/Updates
 Table 145. jMedtech Company Information
 Table 146. jMedtech Description and Business Overview
 Table 147. jMedtech Medical Anti-Thrombotic Coating Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 148. jMedtech Medical Anti-Thrombotic Coating Product
 Table 149. jMedtech Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Medical Anti-Thrombotic Coating Distributors List
 Table 153. Medical Anti-Thrombotic Coating Customers List
 Table 154. Medical Anti-Thrombotic Coating Market Trends
 Table 155. Medical Anti-Thrombotic Coating Market Drivers
 Table 156. Medical Anti-Thrombotic Coating Market Challenges
 Table 157. Medical Anti-Thrombotic Coating Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Anti-Thrombotic Coating
 Figure 2. Global Medical Anti-Thrombotic Coating Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Medical Anti-Thrombotic Coating Market Share by Type: 2025 & 2032
 Figure 4. Thin Coating Product Picture
 Figure 5. Thick Coating Product Picture
 Figure 6. Global Medical Anti-Thrombotic Coating Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Medical Anti-Thrombotic Coating Market Share by Application: 2025 & 2032
 Figure 8. Catheter
 Figure 9. Stent Delivery System
 Figure 10. Guide Wire
 Figure 11. Others
 Figure 12. Global Medical Anti-Thrombotic Coating Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Medical Anti-Thrombotic Coating Market Size (US$ Million), 2021–2032
 Figure 14. Global Medical Anti-Thrombotic Coating Sales (Kilotons), 2021–2032
 Figure 15. Global Medical Anti-Thrombotic Coating Average Price (US$/Ton), 2021–2032
 Figure 16. Medical Anti-Thrombotic Coating Report Years Considered
 Figure 17. Medical Anti-Thrombotic Coating Sales Share by Manufacturers in 2025
 Figure 18. Global Medical Anti-Thrombotic Coating Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Medical Anti-Thrombotic Coating Players: Market Share by Revenue in Medical Anti-Thrombotic Coating in 2025
 Figure 20. Medical Anti-Thrombotic Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Medical Anti-Thrombotic Coating Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
 Figure 23. North America Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
 Figure 24. United States Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
 Figure 27. Europe Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Medical Anti-Thrombotic Coating Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Medical Anti-Thrombotic Coating Revenue Market Share by Region (2021–2032)
 Figure 35. China Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Medical Anti-Thrombotic Coating Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Medical Anti-Thrombotic Coating Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Medical Anti-Thrombotic Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Medical Anti-Thrombotic Coating by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Medical Anti-Thrombotic Coating by Type (2021–2032)
 Figure 55. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Medical Anti-Thrombotic Coating by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Medical Anti-Thrombotic Coating by Application (2021–2032)
 Figure 58. Global Medical Anti-Thrombotic Coating Price (US$/Ton) by Application (2021–2032)
 Figure 59. Medical Anti-Thrombotic Coating Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String